NCT05096143View on ClinicalTrials.gov

A Cohort Study to Compare the Hospitalization Between Naive Sacubitril/Valsartan and Naive ACEi/ARBs Heart Failure Patients With Reduced Ejection Fraction Using Secondary US Electronic Health Records Data

CompletedOBSERVATIONAL
Enrollment

42,269

Participants

Timeline

Start Date

June 3, 2020

Primary Completion Date

October 19, 2020

Study Completion Date

October 19, 2020

Conditions
Heart Failure
Interventions
DRUG

Sacubitril/valsartan

Participants who were prescribed with Sacubitril/valsartan

DRUG

ACEi/ARB

Participants who were prescribed with Angiotensin-converting enzyme inhibitors/Angiotensin II receptor antagonists (ACEi/ARB)

Trial Locations (1)

07936

Novartis Investigative Site, East Hanover

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY